Ut Southwestern Medical Center At Dallas

Dallas, Texas 75390-9179

6 studies enrolling now · 83 studies all time

What they study most

ACE Inhibitor Induced Angioedema, Acute Liver Failure, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Administration Site Reaction, Alcohol Dependence, Alzheimer's Disease, Anaplastic Lymphoma Kinase (ALK) Positive, Arrhythmia, Arthritis, Rheumatoid, Asthma, Benign Prostatic Hyperplasia

Studies at this site

• A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer — Recruiting now
• A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC) — Recruiting now
• IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study) — Recruiting now
• A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer — Recruiting now
• A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer — Recruiting now
• Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study — Recruiting now
• Non-Invasive Testing to Evaluate Wound Healing in Diabetes — Recruiting now
• Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma — Completed
• A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer — Running, not enrolling
• Selexipag (ACT-293987) in Pulmonary Arterial Hypertension — Completed
• Celliant Socks to Increase Tissue Oxygenation and Complete Wound Closure in Diabetic Foot Wounds — Stopped early
• Phase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Dehydrogenase Isoform 2 (IDH2) Mutation — Completed
• Evaluation of the Spiration® Valve System for Emphysema to Improve Lung Function — Completed
• Treatment of Foot and Leg Ulcers Using a Laser — Completed
• Cryopreserved vs. Lyopreserved Stravix as an Adjunct to NPWT in the Treatment of Complex Wounds — Completed
• RCT to Compare Restrata and NPWT to Heal Complex DFUs — Withdrawn before enrolling
• Characterization of AmnioExcel Plus in Two Treatment Paradigms — Completed
• Inflammatory Biomarkers to Diagnose and Monitor Diabetic Foot Osteomyelitis — Completed
• The Effect of Implementing a Limb Loss Prevention Program on Amputation Rates — Completed
• GrafixPL PRIME Evaluation Case Study — Completed
• Continuous Diffusion of Oxygen (CDO) Treatment for Healing of Diabetic Foot Ulcers — Completed
• UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repository — Completed
• Negative Pressure Wound Therapy as a Drug Delivery System — Completed
• Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma — Completed
• Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012) — Completed
• 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease — Stopped early
• Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients — Completed
• Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema — Stopped early
• Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis — Stopped early
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed
• Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) — Completed
• Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression — Status unconfirmed
• 13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF — Completed
• A Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (ENDURANCE SUPPLEMENTAL TRIAL) — Completed
• Therapeutic Stockings to Prevent Foot Ulcers — Completed
• Instant Total Contact Cast to Heal Diabetic Foot Ulcers — Completed
• Electrical Stimulation for Improving Balance in Diabetes — Completed
• Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder — Completed
• Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI) — Completed
• Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis — Completed
• A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia — Completed
• A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer — Completed
• Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer — Completed
• HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone) — Completed
• Study to Evaluate Bacterial Activity That Drives the Progression of Clinical Infection — Withdrawn before enrolling
• Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus — Completed
• A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia — Completed
• Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy — Completed
• Gilead Sustained Virologic Response (SVR) Registry — Completed
• Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML — Completed